Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Invitae
MedTech
Labcorp picks up Invitae portfolio for $239M in bankruptcy sale
According to Invitae the transaction covers “substantially all of the company’s assets”—though the testing giant Labcorp described them as “select.”
Conor Hale
Apr 26, 2024 11:01am
Invitae files for bankruptcy, prepares for a sale
Feb 14, 2024 11:45am
Invitae is reportedly preparing to file for bankruptcy: WSJ
Feb 8, 2024 1:14pm
Natera offers Invitae $52.5M for prenatal screening tests
Jan 22, 2024 10:27am
JPM23: What's medtech's place at the conference? CEOs weigh in
Jan 12, 2023 9:45am
JPM23's Medtech Tidbits: Reporting from San Francisco
Jan 11, 2023 11:11am
